Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
TEST:
PulmoSeek Lung Cancer Early Detection Assay
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
AnchorDx
Type:
CE Marked
Related tests:
‹
AnchorAIM® 10 Gene Test for Individualized Treatment of Lung Cancer
AnchorAIM® 72 gene detection for individualized treatment of solid tumors
AnchorAIM® Personalized Treatment of Colorectal Cancer 11 Gene Test
AnchorIRIS™
UriFind® Methylation Test
AnchorAIM® 10 Gene Test for Individualized Treatment of Lung Cancer
AnchorAIM® 72 gene detection for individualized treatment of solid tumors
AnchorAIM® Personalized Treatment of Colorectal Cancer 11 Gene Test
AnchorIRIS™
UriFind® Methylation Test
›
Details
Evidence
News
PulmoSeek uses cell-free DNA methylation analysis to identify epigenetic patterns specific to malignant cells and is intended for cancer detection and diagnosis in individuals with pulmonary nodules between 5 and 30 millimeters.
Cancer:
Lung Cancer
Method:
Cell-free DNA methylation analysis
Approvals
Date
Cancer
Gene
Biomarker
Drug
Approved by
06/15/2022
Lung Cancer
-
-
CE Marked
Approvals
Date
Cancer
Gene
Drug
By
06/15/22
LC
-
CE
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login